Author: admin

OPTIMIZATION OF HEART RATE-LOWERING THERAPY IN HOSPITALIZED PATIENTS WITH HEART FAILURE: INSIGHTS FROM THE OPTIMIZE HEART FAILURE CARE PROGRAM

Hospitalization provides an opportunity to re-evaluate patient care, including optimization of current therapy and planning of longer-term management. A substantial proportion of patients hospitalized with HFrEF have an elevated heart rate at discharge, and a heart rate ≥70 bpm is associated with increased risk of mortality or hospitalization.

This paper discusses the effects of in-hospital co-administration of a β-blocker and ivabradine versus a β-blocker alone on mortality, rehospitalization, and quality of life in hospitalized patients taking part in the Optimize Heart Failure Care Program in Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Russia, Ukraine, and Uzbekistan.

In this retrospective analysis, heart rate-lowering therapy with a β-blocker + ivabradine started in hospitalized HF patients was associated with reduced overall mortality and re-hospitalization over the subsequent 12 months.

Link to article:
Lopatin YM, Cowie MR, Grebennikova AA, [IJC]
Optimization of heart rate lowering therapy in hospitalized patients with heart failure:
Insights from the Optimize Heart Failure Care Program.
Int J Cardiol. 2018 Jun 1;260:113-117.

Link to editorial:
Stewart Coats AJ. [IJC]
Heart rate as a target: Ready for pole position? Int J Cardiol. 2018 Jun 1;260:131-132.

2nd test newsletter

elhorar o manejo dos pacientes com insuficiência cardíaca

text lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsumtext lorem ipsum

Patient Support Program

Editorial

Recently, programs for optimizing heart failure management have been considered as a promising approach to reducing re-hospitalizations and even major adverse cardiovascular events.
The Optimize program for cardiologists in Eastern Europe and Central Asia counts 12 centers in Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Russia, Ukraine, and Uzbekistan, specializing in management of patients with heart failure that are participating in our program.
Therefore, we have a unique opportunity to demonstrate the benefits of the program for optimizing heart failure management, not only for cardiologists, but also for the health authorities of our countries.

One of the goals of this international project is to evaluate the management of patients with heart failure in accordance with current international and national guidelines.
From a practical point of view the information obtained will allow us to identify the issues that should be focused on by cardiologists to optimize the management of patients with heart failure in Eastern Europe and Central Asia.

To capitalize on the Optimize programs, we plan to present the results at international and national congresses, to produce joint publications, and to make proposals to improve the management of patients with heart failure in our countries.